Tag: bioequivalence

item-image

Bioequivalence for Inhalers, Patches, and Injections: What Generic Drug Developers Really Face

Bioequivalence for inhalers, patches, and injectables requires more than blood tests-it demands matching how the drug is delivered to the body. Learn why these generics are harder to make, why they cost more, and what really makes them work.

Read More
item-image

Why Some People React Differently to Generic Medications

Generic medications save billions, but not everyone reacts the same. For drugs with narrow therapeutic indices like levothyroxine and warfarin, small differences in absorption can cause serious side effects. Here’s why some people feel worse after switching-and what to do about it.

Read More
item-image

Combination NTI Drugs and Generic Availability: Coverage and Gaps

Combination NTI drugs offer precise treatment for complex conditions but face major gaps in generic availability due to bioequivalence challenges. Patients risk therapeutic failure or toxicity when generics are substituted, with no FDA-approved fixed-dose NTI combinations currently on the U.S. market.

Read More